Grant GrossMendelsohn LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, Holdings Channel.com reports. The fund bought 548 shares of the healthcare conglomerate’s stock, valued at approximately $218,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Accel Wealth Management acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Atlas Private Wealth Advisors increased its position in UnitedHealth Group by 46.2% during the first quarter. Atlas Private Wealth Advisors now owns 95 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 30 shares during the period. Sage Private Wealth Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $36,000. IronBridge Private Wealth LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at $37,000. Finally, Costello Asset Management INC increased its stake in UnitedHealth Group by 500.0% in the fourth quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 100 shares during the period. 86.03% of the stock is owned by hedge funds and other institutional investors.
Shares of UNH opened at $409.80 on Friday. The company’s 50 day simple moving average is $389.73 and its 200 day simple moving average is $353.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.82 and a current ratio of 0.82. The company has a market capitalization of $386.73 billion, a price-to-earnings ratio of 23.54, a PEG ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a 1 year low of $273.71 and a 1 year high of $425.98.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were issued a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.22%. UnitedHealth Group’s payout ratio is 33.09%.
In related news, EVP Patricia L. Lewis sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, April 16th. The shares were sold at an average price of $389.99, for a total value of $1,169,970.00. Following the transaction, the executive vice president now owns 9,214 shares in the company, valued at $3,593,367.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 4,000 shares of the stock in a transaction on Monday, March 15th. The stock was sold at an average price of $353.32, for a total transaction of $1,413,280.00. Following the completion of the sale, the director now directly owns 153,953 shares of the company’s stock, valued at approximately $54,394,673.96. The disclosure for this sale can be found here. Insiders have sold 14,801 shares of company stock valued at $5,653,468 in the last ninety days. 0.80% of the stock is currently owned by company insiders.
Several research analysts have weighed in on the company. Truist lifted their target price on UnitedHealth Group from $420.00 to $450.00 in a research note on Wednesday, April 14th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $462.00 to $515.00 and gave the company an “overweight” rating in a research note on Thursday, April 22nd. Barclays lifted their target price on shares of UnitedHealth Group from $405.00 to $435.00 and gave the company an “overweight” rating in a report on Thursday, April 22nd. Oppenheimer boosted their target price on UnitedHealth Group from $375.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $409.00 to $418.00 and gave the stock a “buy” rating in a report on Thursday, April 22nd. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $412.26.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Read More: Retained Earnings
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.